Work
Targeting PRC2-regulated, super enhancer-driven transcription factors to treat malignant peripheral nerve sheath tumors
上市 DepositedMLA citation style (9th ed.)
. 2020. marian.hykucommons.org/concern/generic_works/5eb6cbf3-84b9-429d-a746-e5c0d76c8cb7?locale=zh. Targeting Prc2-regulated, Super Enhancer-driven Transcription Factors to Treat Malignant Peripheral Nerve Sheath Tumors.APA citation style (7th ed.)
(2020). Targeting PRC2-regulated, super enhancer-driven transcription factors to treat malignant peripheral nerve sheath tumors. https://marian.hykucommons.org/concern/generic_works/5eb6cbf3-84b9-429d-a746-e5c0d76c8cb7?locale=zhChicago citation style (CMOS 17, author-date)
Targeting Prc2-Regulated, Super Enhancer-Driven Transcription Factors to Treat Malignant Peripheral Nerve Sheath Tumors. 2020. https://marian.hykucommons.org/concern/generic_works/5eb6cbf3-84b9-429d-a746-e5c0d76c8cb7?locale=zh.Note: These citations are programmatically generated and may be incomplete.
- Creator
- Language
- 关键词
- Date created
- Related URL
- Resource type
- Rights statement
关系
项目
缩图 | 标题 | 上载日期 | 能见度 | 动作 |
---|---|---|---|---|
Hannah_Lou.pdf | 2021-10-22 | 上市 | 下载 |